• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Incyte Corporation (INCY)

    -NasdaqGS
    94.36 Up 5.16(5.78%) Mar 27, 4:00PM EDT
    |After Hours : 94.36 0.00 (0.00%) Mar 27, 4:12PM EDT
    Add to Portfolio
    Prev Close:89.20
    Open:89.72
    Bid:94.00 x 200
    Ask:115.52 x 100
    1y Target Est:91.75
    Beta:0.16
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:89.05 - 95.72
    52wk Range:40.30 - 99.00
    Volume:1,401,500
    Avg Vol (3m):1,187,180
    Market Cap:16.21B
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INCY

    Comparison

    Symbol% ChgMkt Cap
    INCYUp 5.78%16.21B
    AMGNUp 1.27%123.38B
    CELGUp 0.87%95.01B
    RHHBYDown 0.23%N/A

    Key Statistics

    Forward P/E (1 yr):89.87
    P/S (ttm):29.95
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.22
    Quarterly EPS Est (Mar-15) :-0.07
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-4.83

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback